Orbimed Advisors as of March 31, 2022
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 141 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Springworks Therapeutics (SWTX) | 5.5 | $340M | 6.0M | 56.44 | |
Horizon Therapeutics Pub L SHS | 3.7 | $231M | 2.2M | 105.21 | |
Boston Scientific Corporation (BSX) | 3.3 | $204M | 4.6M | 44.29 | |
Pfizer (PFE) | 3.3 | $202M | 3.9M | 51.77 | |
Theseus Pharmaceuticals | 3.2 | $197M | 17M | 11.53 | |
Bristol Myers Squibb (BMY) | 3.1 | $190M | 2.6M | 73.03 | |
Humana (HUM) | 2.7 | $166M | 382k | 435.17 | |
Intuitive Surgical Com New (ISRG) | 2.6 | $161M | 534k | 301.68 | |
UnitedHealth (UNH) | 2.4 | $150M | 294k | 509.97 | |
Adicet Bio (ACET) | 2.4 | $149M | 7.4M | 19.97 | |
Abbvie (ABBV) | 2.4 | $148M | 916k | 162.11 | |
Pmv Pharmaceuticals (PMVP) | 2.3 | $143M | 6.9M | 20.82 | |
Edgewise Therapeutics (EWTX) | 2.2 | $135M | 14M | 9.70 | |
Mirati Therapeutics | 2.2 | $134M | 1.6M | 82.22 | |
BioMarin Pharmaceutical (BMRN) | 2.1 | $127M | 1.6M | 77.10 | |
Edwards Lifesciences (EW) | 2.0 | $124M | 1.1M | 117.72 | |
Stryker Corporation (SYK) | 2.0 | $122M | 457k | 267.35 | |
Arcutis Biotherapeutics (ARQT) | 1.9 | $117M | 6.1M | 19.26 | |
Iovance Biotherapeutics (IOVA) | 1.8 | $110M | 6.6M | 16.65 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.7 | $104M | 400k | 260.97 | |
Seagen | 1.6 | $96M | 668k | 144.05 | |
Keros Therapeutics (KROS) | 1.5 | $91M | 1.7M | 54.38 | |
Guardant Health (GH) | 1.4 | $88M | 1.3M | 66.24 | |
Biohaven Pharmaceutical Holding | 1.4 | $85M | 719k | 118.57 | |
Tricida | 1.4 | $85M | 10M | 8.22 | |
Neurocrine Biosciences (NBIX) | 1.3 | $82M | 876k | 93.75 | |
Dex (DXCM) | 1.2 | $77M | 150k | 511.60 | |
Ikena Oncology Nonvoting | 1.2 | $73M | 12M | 6.10 | |
Thermo Fisher Scientific (TMO) | 1.2 | $71M | 121k | 590.65 | |
Natera Call Option (NTRA) | 1.2 | $71M | 1.7M | 40.68 | |
Si-bone (SIBN) | 1.2 | $71M | 3.1M | 22.60 | |
Crinetics Pharmaceuticals In (CRNX) | 1.1 | $70M | 3.2M | 21.95 | |
Prelude Therapeutics (PRLD) | 1.1 | $69M | 10M | 6.90 | |
Sierra Oncology Com New | 1.0 | $63M | 2.0M | 32.05 | |
Global Blood Therapeutics In | 0.9 | $56M | 1.6M | 34.64 | |
Turning Point Therapeutics I | 0.9 | $54M | 2.0M | 26.85 | |
Tenet Healthcare Corp Com New (THC) | 0.9 | $54M | 628k | 85.96 | |
Argenx Se Sponsored Adr (ARGX) | 0.9 | $54M | 170k | 315.31 | |
Xtant Med Hldgs Com New (XTNT) | 0.8 | $50M | 73M | 0.68 | |
Repare Therapeutics Ord (RPTX) | 0.8 | $47M | 3.3M | 14.24 | |
Meiragtx Holdings (MGTX) | 0.7 | $46M | 3.3M | 13.85 | |
Kinnate Biopharma | 0.7 | $46M | 4.0M | 11.26 | |
Evolent Health Cl A (EVH) | 0.7 | $45M | 1.4M | 32.30 | |
Abcellera Biologics (ABCL) | 0.7 | $41M | 4.2M | 9.75 | |
Janux Therapeutics (JANX) | 0.7 | $41M | 2.8M | 14.34 | |
Nanostring Technologies (NSTGQ) | 0.7 | $40M | 1.2M | 34.75 | |
Syndax Pharmaceuticals (SNDX) | 0.6 | $38M | 2.2M | 17.38 | |
Alpine Immune Sciences | 0.6 | $37M | 4.1M | 8.97 | |
Vaxcyte (PCVX) | 0.6 | $37M | 1.5M | 24.15 | |
Tela Bio (TELA) | 0.6 | $35M | 3.0M | 11.63 | |
Neuropace (NPCE) | 0.5 | $33M | 4.0M | 8.21 | |
Theravance Biopharma (TBPH) | 0.5 | $31M | 3.3M | 9.56 | |
Silverback Therapeutics (SPRY) | 0.5 | $31M | 8.7M | 3.51 | |
Compass Therapeutics (CMPX) | 0.5 | $30M | 22M | 1.37 | |
Verona Pharma Sponsored Ads (VRNA) | 0.5 | $28M | 5.7M | 4.99 | |
Scpharmaceuticals (SCPH) | 0.4 | $27M | 4.8M | 5.68 | |
Aclaris Therapeutics (ACRS) | 0.4 | $27M | 1.6M | 17.24 | |
Gh Research Ordinary Shares (GHRS) | 0.4 | $26M | 1.4M | 18.29 | |
Vectivbio Hldg Ord Shs | 0.4 | $25M | 5.3M | 4.71 | |
Fusion Pharmaceuticals | 0.4 | $25M | 3.2M | 7.77 | |
Biogen Idec (BIIB) | 0.4 | $25M | 118k | 210.60 | |
Chinook Therapeutics | 0.4 | $23M | 1.4M | 16.36 | |
Adagio Therapeutics (IVVD) | 0.4 | $23M | 5.1M | 4.56 | |
Passage Bio (PASG) | 0.4 | $23M | 7.3M | 3.10 | |
Xenon Pharmaceuticals (XENE) | 0.3 | $21M | 686k | 30.57 | |
Jounce Therapeutics | 0.3 | $19M | 2.9M | 6.79 | |
Mereo Biopharma Group Ads (MREO) | 0.3 | $19M | 17M | 1.12 | |
Mersana Therapeutics (MRSN) | 0.3 | $19M | 4.8M | 3.99 | |
Gracell Biotechnologies Sponsored Ads | 0.3 | $18M | 7.9M | 2.33 | |
Ikena Oncology (IKNA) | 0.3 | $18M | 2.9M | 6.10 | |
Ventyx Biosciences (VTYX) | 0.3 | $18M | 1.3M | 13.57 | |
Rxsight (RXST) | 0.3 | $17M | 1.4M | 12.38 | |
Gilead Sciences (GILD) | 0.3 | $17M | 288k | 59.45 | |
Uniqure Nv SHS (QURE) | 0.3 | $17M | 919k | 18.07 | |
Milestone Pharmaceuticals (MIST) | 0.3 | $17M | 2.6M | 6.42 | |
Ultragenyx Pharmaceutical (RARE) | 0.3 | $17M | 228k | 72.62 | |
Vistagen Therapeutics Com New | 0.3 | $16M | 13M | 1.24 | |
Illumina (ILMN) | 0.3 | $16M | 45k | 349.40 | |
Harpoon Therapeutics | 0.2 | $15M | 3.0M | 4.97 | |
Decibel Therapeutics | 0.2 | $15M | 4.9M | 3.04 | |
Singular Genomics Systems In | 0.2 | $15M | 2.3M | 6.31 | |
Synlogic | 0.2 | $15M | 6.0M | 2.40 | |
Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $14M | 30M | 0.48 | |
Erasca (ERAS) | 0.2 | $14M | 1.7M | 8.60 | |
Celldex Therapeutics Com New (CLDX) | 0.2 | $14M | 406k | 34.06 | |
Amgen (AMGN) | 0.2 | $14M | 57k | 241.82 | |
89bio (ETNB) | 0.2 | $14M | 3.7M | 3.77 | |
Burning Rock Biotech Sponsored Ads | 0.2 | $14M | 1.5M | 9.29 | |
Nextcure (NXTC) | 0.2 | $13M | 2.7M | 4.86 | |
Galapagos Nv Spon Adr (GLPG) | 0.2 | $13M | 208k | 62.02 | |
Danaher Corporation 5% Conv Pfd B (Principal) | 0.2 | $13M | 8.0k | 1579.30 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.2 | $12M | 2.6M | 4.80 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $12M | 20M | 0.60 | |
Corvus Pharmaceuticals (CRVS) | 0.2 | $11M | 6.9M | 1.64 | |
Signify Health Cl A Com | 0.2 | $11M | 621k | 18.15 | |
Terns Pharmaceuticals (TERN) | 0.2 | $11M | 3.8M | 2.97 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $11M | 2.1M | 5.34 | |
Pulmonx Corp (LUNG) | 0.2 | $11M | 435k | 24.81 | |
Alx Oncology Hldgs (ALXO) | 0.2 | $11M | 622k | 16.90 | |
Bellus Health Com New | 0.2 | $10M | 1.5M | 6.92 | |
Spdr Ser Tr S&p Biotech (XBI) | 0.2 | $10M | 112k | 89.88 | |
Aerovate Therapeutics (AVTE) | 0.2 | $9.3M | 510k | 18.33 | |
Galecto (GLTO) | 0.1 | $9.0M | 4.1M | 2.20 | |
Cybin Ord (CYBN) | 0.1 | $8.6M | 11M | 0.82 | |
Imara | 0.1 | $8.2M | 4.4M | 1.88 | |
Gemini Therapeutics | 0.1 | $8.1M | 5.8M | 1.39 | |
Graphite Bio | 0.1 | $8.0M | 1.6M | 5.10 | |
Rapt Therapeutics (RAPT) | 0.1 | $7.9M | 361k | 21.99 | |
Sonendo (SONX) | 0.1 | $7.9M | 2.0M | 4.01 | |
Cullinan Oncology (CGEM) | 0.1 | $7.0M | 671k | 10.47 | |
Aeglea Biotherapeutics | 0.1 | $6.8M | 3.0M | 2.30 | |
Magenta Therapeutics | 0.1 | $6.5M | 2.3M | 2.90 | |
9 Meters Biopharma | 0.1 | $6.2M | 10M | 0.60 | |
Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $6.1M | 6.0M | 1.01 | |
Albireo Pharma | 0.1 | $5.8M | 194k | 29.83 | |
Logicbio Therapeutics | 0.1 | $5.8M | 8.5M | 0.68 | |
Cytomx Therapeutics (CTMX) | 0.1 | $5.7M | 2.1M | 2.67 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $5.4M | 2.8M | 1.93 | |
Oncocyte | 0.1 | $5.2M | 3.5M | 1.49 | |
Graybug Vision Com Shs | 0.1 | $5.1M | 4.2M | 1.23 | |
Vor Biopharma (VOR) | 0.1 | $5.0M | 833k | 6.04 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $4.7M | 1.6M | 2.94 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $4.2M | 831k | 5.11 | |
Immunocore Hldgs Ads (IMCR) | 0.1 | $3.8M | 128k | 29.90 | |
Acutus Medical (AFIB) | 0.1 | $3.7M | 2.6M | 1.39 | |
Sarepta Therapeutics (SRPT) | 0.0 | $3.1M | 39k | 78.11 | |
Vigil Neuroscience (VIGL) | 0.0 | $2.9M | 411k | 7.03 | |
Talaris Therapeutics | 0.0 | $2.4M | 247k | 9.84 | |
X4 Pharmaceuticals (XFOR) | 0.0 | $2.4M | 1.4M | 1.75 | |
Sight Sciences (SGHT) | 0.0 | $2.3M | 200k | 11.56 | |
I Mab Sponsored Ads (IMAB) | 0.0 | $1.8M | 111k | 16.24 | |
Exscientia Ads (EXAI) | 0.0 | $1.8M | 125k | 14.40 | |
Aslan Pharmaceuticals Ads | 0.0 | $1.7M | 1.9M | 0.90 | |
Aptinyx | 0.0 | $1.2M | 539k | 2.27 | |
Cabaletta Bio (CABA) | 0.0 | $1.2M | 578k | 2.03 | |
Field Trip Health Ord | 0.0 | $762k | 577k | 1.32 | |
Longboard Pharmaceuticals In (LBPH) | 0.0 | $606k | 114k | 5.34 | |
Mirum Pharmaceuticals (MIRM) | 0.0 | $595k | 27k | 22.04 | |
Pyxis Oncology Common Stock (PYXS) | 0.0 | $580k | 144k | 4.04 | |
Landos Biopharma | 0.0 | $418k | 283k | 1.48 | |
Owlet *w Exp 09/14/202 (OWLTW) | 0.0 | $170k | 221k | 0.77 |